Loda for his dedication and leadership in helming the center as interim director for the past year.”ĭr. We would like to express our gratitude to Dr. “His leadership and experience will be instrumental in elevating the groundbreaking work of the Meyer Cancer Center and further enhancing the innovative, personalized and compassionate cancer care we provide to patients in all the communities we serve. Corwin, president and CEO of NewYork-Presbyterian. We are delighted to welcome him as the new director of the Meyer Cancer Center,” said Dr. Wolchok is a renowned physician-scientist and exceptional leader whose pioneering research in immunotherapy has fundamentally changed the way we approach cancer care and improved the lives of countless patients. Collaborations between basic scientists and physicians are accelerating the application of these findings into clinical care, while partnerships with community stakeholders help to rapidly translate cancer prevention and detection discoveries into new outreach programs for the communities that need it most. The Meyer Cancer Center focuses on multidisciplinary, high-impact science, harnessing cutting-edge technology and new biomedical approaches to illuminate the biological conditions that allow cancer to develop and proliferate. “His strong leadership and vast experience in this area of medicine have allowed the center to continue its vital, groundbreaking work in cancer research and care.”Ĭreated in 2014 with a $75 million gift from Sandra and Edward Meyer and the Sandra and Edward Meyer Foundation, the Weill Cornell Medicine Meyer Cancer Center, in partnership with NewYork-Presbyterian, unifies cancer research throughout Weill Cornell Medicine and has more than 140 core members, including basic scientists, surgeons, oncologists, radiologists, pathologists and other clinicians. Loda for his dedicated service as interim director of the Meyer Cancer Center over the past year,” Dr. “His expertise and vision will be crucial as the institution enhances cancer research and treatment efforts throughout the city, providing critical care and hope to cancer patients, and building on the center’s outstanding reputation as a leader in this field.
Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine.
We are thrilled he will be heading the Meyer Cancer Center,” said Dr. Wolchok is a distinguished physician-scientist and an esteemed leader in oncology, whose innovative research in immunotherapy has transformed the prognosis for countless melanoma patients and will undoubtedly have lasting implications for other types of cancer. Lewis Cantley, the center’s founding Meyer Director. Massimo Loda, chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine, who has served as interim director since last year’s departure of Dr. Ludwig Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center (MSK), and he is a professor of medicine at Weill Cornell Medicine. Wolchok currently serves as chief of the Immuno-Oncology Service and the Lloyd J. Wolchok will also expand the exemplary care delivered at the institution’s flagship Upper East Side Manhattan location and further enhance care for patients in Brooklyn and Queens.ĭr. Wolchok will lead an expansive, multidisciplinary research and clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. Taha Merghoub (left), deputy director of the Meyer Cancer Center - Weill Cornell Medicineĭr. Jedd Wolchok (right), recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center with Dr.
0 kommentar(er)
